Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (401-410 of 519) with videos related to

Pageof 52
Sort By:
European Urology Oncology|September 30, 2019
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial CancerHeather J Chalfin, Stephanie A Glavaris, Michael A Gorin, et al.
Cancer Research|October 12, 2007
Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate cancer therapyEvan T Keller, David R Rowley, Scott A Tomlins, et al.
The Prostate|August 27, 2019
Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancerFrank C Cackowski, Yugang Wang, Joseph T Decker, et al.
Cancer Research|March 16, 2021
Retraction: A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate CancerJianhua Wang, Jincheng Wang, Jinlu Dai, et al.
Molecular Imaging and Biology|May 30, 2019
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Impact of Tumor Burden on Normal Organ UptakeRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
STAR Protocols|October 28, 2025
Protocol to model tumor hypoxia in vitro using real-time phosphorescence-based sensing of O<sub>2</sub> gradients generated by metastatic cancer cellsNoreen Hosny, Kimberly Shen, Yihua Zhao, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
Galectin-3 as a potential therapeutic target in tumors arising from malignant endotheliaKim D Johnson, Olga V Glinskii, Valeri V Mossine, et al.
Neoplasia (New York, N.Y.)|April 9, 2008
An in vivo mouse model for human prostate cancer metastasisAaron M Havens, Elisabeth A Pedersen, Yusuke Shiozawa, et al.
Nature|October 11, 2002
The polycomb group protein EZH2 is involved in progression of prostate cancerSooryanarayana Varambally, Saravana M Dhanasekaran, Ming Zhou, et al.
Plos One|August 13, 2013
Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxiaHeather H Cheng, Patrick S Mitchell, Evan M Kroh, et al.
Pageof 52

Showing results (401-410 of 519) with videos related to

Sort By:
Pageof 52
European Urology Oncology|September 30, 2019
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial CancerHeather J Chalfin, Stephanie A Glavaris, Michael A Gorin, et al.
Cancer Research|October 12, 2007
Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate cancer therapyEvan T Keller, David R Rowley, Scott A Tomlins, et al.
The Prostate|August 27, 2019
Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancerFrank C Cackowski, Yugang Wang, Joseph T Decker, et al.
Cancer Research|March 16, 2021
Retraction: A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate CancerJianhua Wang, Jincheng Wang, Jinlu Dai, et al.
Molecular Imaging and Biology|May 30, 2019
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Impact of Tumor Burden on Normal Organ UptakeRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
STAR Protocols|October 28, 2025
Protocol to model tumor hypoxia in vitro using real-time phosphorescence-based sensing of O<sub>2</sub> gradients generated by metastatic cancer cellsNoreen Hosny, Kimberly Shen, Yihua Zhao, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
Galectin-3 as a potential therapeutic target in tumors arising from malignant endotheliaKim D Johnson, Olga V Glinskii, Valeri V Mossine, et al.
Neoplasia (New York, N.Y.)|April 9, 2008
An in vivo mouse model for human prostate cancer metastasisAaron M Havens, Elisabeth A Pedersen, Yusuke Shiozawa, et al.
Nature|October 11, 2002
The polycomb group protein EZH2 is involved in progression of prostate cancerSooryanarayana Varambally, Saravana M Dhanasekaran, Ming Zhou, et al.
Plos One|August 13, 2013
Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxiaHeather H Cheng, Patrick S Mitchell, Evan M Kroh, et al.
Pageof 52